4,4-Difluoropiperidine hydrochloride

We are 4,4-Difluoropiperidine hydrochloride CAS:144230-52-4 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:4,4-Difluoropiperidine hydrochloride
CAS.NO:144230-52-4
Synonyms:4,4-difluoropiperidine,hydrochloride
Piperidine, 4,4-difluoro-, hydrochloride
Molecular Formula:C5H10ClF2N
Molecular Weight:157.58900
 
Physical and Chemical Properties:
Density:1.222
Melting point:173-177ºC
Index of Refraction:1.472
 
Specification:
Appearance:Light-Yellow Solid
Assay(GC):≥99.0%
Moisture:≤0.5%
The Largest Impurity:≤0.1%
Melting point:173-177ºC
Residue on Ignition:≤0.1%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate in organic syntheses

4,4-Difluoropiperidine hydrochloride


Related News: In addition, with the increase of environmental protection pressure, nearly one hundred Beijing pharmaceutical companies have gathered in the Bohai Bay, and the raw material drug base in northern China has taken shape.1,6-Dibromopyrene CAS:27973-29-1 Catalent, a global leader in clinical supply services, recently announced the launch of its new CTSuccessTM clinical trial planning service, designed to support trial sponsors with earlier, more proactive and robust clinical supply chain planning, and reduce the risk of delays and budget overspend common to clinical trials as they progress.1198396-46-1 Bulk drug substances mainly include vitamins, antibiotics, hormones, antipyretics and analgesics, among which vitamin C, erythromycin thiocyanate, penicillin, azithromycin, and semi-synthetic cephalosporins are the most concentrated products in the industry in terms of production and overcapacity.Spiro[9H-fluorene-9,9'-[9H]xanthene], 2-bromo- Factors that have a significant impact on the sales volume of APIs come from the production side, which mainly includes costs and processes.The CRL for the Cabenuva injection, containing two active ingredients cabotegravir and Janssen’s rilpivirine, follows U.S. market approval in April for its once-a-day pill Dovato, also a two-drug combination.

Related Products
Product Name
2-Methyl-5-formylpyridine View Details
2-Ethoxyphenyl isothiocyanate View Details
4-Fluoro-2-methylbenzonitrile View Details
1,1,1-trifluoro-2-iodoethane manufacturer 2,2′-(5-bromo-1,3-phenylene)dipyridine manufacturer 2-Bromo-5-chlorophenol manufacturer Bis(2-ethylhexyl) adipate manufacturer Acetyl Tetrapeptide-2 manufacturer